Recombinant Human kynurenine 3-monooxygenase protein is a Human Full Length protein, in the 1 to 407 aa range, expressed in Wheat germ and suitable for SDS-PAGE, ELISA, WB.
M D S S V I Q R K K V A V I G G G L V G S L Q A C F L A K R N F Q I D V Y E A R E D T R V A T F T R G R S I N L A L S H R G R Q A L K A V G L E D Q I V S Q G I P M R A R M I H S L S G K K S A I P Y G T K S Q Y I L S V S R E N L N K D L L T A A E K Y P N V K M H F N H R L L K C N P E E G M I T V L G S D K V P K D V T C D L I V G C D G A Y S T V R S H L M K K P R F D Y S Q Q Y I P H G Y M E L T I P P K N G D Y A M E P N Y L H I W P R N T F M M I A L P N M N K S F T C T L F M P F E E F E K L L T S N D V V D F F Q K Y F P D A I P L I G E K L L V Q D F F L L P A Q P M I S V K C S S F H F K S H C V L L G D A A H A I V P F F G Q G M N A G F E D C L V F D E L M D K F S N D L S L C L P V F S R L R I P D D H A I S D L S M Y N Y I E K N M E R F L H A I M P S T F I P L Y T M V T F S R I R Y H E A V Q R W H W Q K R
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application ELISA | Reactivity Reacts | Dilution info - | Notes - |
Application WB | Reactivity Reacts | Dilution info - | Notes - |
Catalyzes the hydroxylation of L-kynurenine (L-Kyn) to form 3-hydroxy-L-kynurenine (L-3OHKyn) (PubMed:23575632, PubMed:26752518, PubMed:28604669, PubMed:29208702, PubMed:29429898). Required for synthesis of quinolinic acid, a neurotoxic NMDA receptor antagonist and potential endogenous inhibitor of NMDA receptor signaling in axonal targeting, synaptogenesis and apoptosis during brain development. Quinolinic acid may also affect NMDA receptor signaling in pancreatic beta cells, osteoblasts, myocardial cells, and the gastrointestinal tract (Probable).
Kynurenine 3-monooxygenase, Kynurenine 3-hydroxylase, KMO
Recombinant Human kynurenine 3-monooxygenase protein is a Human Full Length protein, in the 1 to 407 aa range, expressed in Wheat germ and suitable for SDS-PAGE, ELISA, WB.
Constituents: 0.79% Tris HCl, 0.31% Glutathione
Catalyzes the hydroxylation of L-kynurenine (L-Kyn) to form 3-hydroxy-L-kynurenine (L-3OHKyn) (PubMed:23575632, PubMed:26752518, PubMed:28604669, PubMed:29208702, PubMed:29429898). Required for synthesis of quinolinic acid, a neurotoxic NMDA receptor antagonist and potential endogenous inhibitor of NMDA receptor signaling in axonal targeting, synaptogenesis and apoptosis during brain development. Quinolinic acid may also affect NMDA receptor signaling in pancreatic beta cells, osteoblasts, myocardial cells, and the gastrointestinal tract (Probable).
Belongs to the aromatic-ring hydroxylase family. KMO subfamily.
Kynurenine 3-monooxygenase (KMO) also known as kynurenine 3-hydroxylase is an enzyme that plays a mechanical role in the kynurenine pathway. This enzyme catalyzes the conversion of L-kynurenine to 3-hydroxykynurenine. KMO has a molecular mass of approximately 55 kDa. It is primarily expressed in the liver and kidney tissues but can also be found in other organs at lower levels. The structure of KMO contains a flavin adenine dinucleotide (FAD) binding domain which is essential for its oxidoreductase activity.
KMO participates in the degradation of tryptophan significantly impacting the biosynthesis of nicotinamide adenine dinucleotide (NAD+). KMO is not known to be part of any protein complexes but its enzymatic activity is important for the production of downstream metabolites that influence various physiological processes. This activity affects immune response neurogenesis and energy metabolism highlighting its role in maintaining metabolic balance.
KMO is an integral component of the kynurenine pathway which is critical for tryptophan catabolism. It associates closely with other enzymes like kynureninase and kynurenine aminotransferase. KMO exerts its function by regulating the levels of neuroactive and immunoactive metabolites in the brain and peripheral tissues. Through its role in the kynurenine pathway KMO influences cellular signaling and energy production connecting to broader metabolic pathways.
KMO plays a significant role in neurodegenerative diseases such as Alzheimer's and Huntington's disease. Altered KMO activity leads to an imbalance of kynurenine pathway metabolites impacting neuronal health. The enzyme's dysfunction also associates with psychiatric disorders like schizophrenia. The relationship between KMO and other kynurenine pathway enzymes like kynurenine aminotransferase suggests that modulating its activity could present therapeutic opportunities for these conditions.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
12.5% SDS-PAGE analysis of ab152891 stained with Coomassie Blue.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com